TANG CAPITAL MANAGEMENT LLC - Q4 2018 holdings

$436 Million is the total value of TANG CAPITAL MANAGEMENT LLC's 10 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 100.0% .

 Value Shares↓ Weighting
ODT BuyODONATE THERAPEUTICS INC$197,785,000
-26.1%
14,047,250
+1.8%
45.38%
+3.8%
HRTX SellHERON THERAPEUTICS INC$150,933,000
-19.9%
5,818,541
-2.2%
34.63%
+12.6%
RCKT  ROCKET PHARMACEUTICALS INC$43,948,000
-39.8%
2,965,4850.0%10.08%
-15.4%
LJPC SellLA JOLLA PHARMACEUTICAL CO$36,578,000
-56.1%
3,878,893
-6.3%
8.39%
-38.3%
PBYI NewPUMA BIOTECHNOLOGY INC$5,035,000247,400
+100.0%
1.16%
OPHT NewOPHTHOTECH CORP$720,000600,000
+100.0%
0.16%
PRTA NewPROTHENA CORP PLC$490,00047,610
+100.0%
0.11%
EQ NewEQUILLIUM INC$386,00047,343
+100.0%
0.09%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
HERON THERAPEUTICS INC37Q3 202355.0%
LA JOLLA PHARMACEUTICAL CO34Q2 202237.1%
ROCKET PHARMACEUTICALS INC20Q3 202331.6%
BIOMARIN PHARMACEUTICAL INC18Q3 201712.1%
ODONATE THERAPEUTICS INC17Q4 202169.8%
ANAPTYSBIO INC16Q3 202318.4%
COHERUS BIOSCIENCES INC15Q3 20232.7%
EQUILLIUM INC13Q3 20231.2%
RELMADA THERAPEUTICS INC12Q4 20226.2%
MIRATI THERAPEUTICS INC11Q3 202310.9%

View TANG CAPITAL MANAGEMENT LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
42024-02-14
42024-02-02
42023-12-18
13F-HR2023-11-14
42023-10-13
13F-HR2023-08-14
32023-06-01
42023-06-01
42023-05-30

View TANG CAPITAL MANAGEMENT LLC's complete filings history.

Compare quarters

Export TANG CAPITAL MANAGEMENT LLC's holdings